Description
Dosing Chart -- Tirzepatide
| Weekly Dosage Amount | ||||||
|---|---|---|---|---|---|---|
| Vial Size (mg) | 1.25mg | 3.75mg | 6.25mg | 8.75mg | 11.25mg | 13.75mg |
| 25mg | 20.0 Weeks | 5.0 Weeks | 3.0 Weeks | 2.0 Weeks | 1.5 Weeks | 1.8 Weeks |
| 50mg | 40.0 Weeks | 10.5 Weeks | 6.0 Weeks | 4.5 Weeks | 3.5 Weeks | 2.5 Weeks |
| 60mg | 48.0 Weeks | 16.0 Weeks | 9.5 Weeks | 6.5 Weeks | 5.0 Weeks | 4.0 Weeks |
| 75mg | 60.0 Weeks | 20.0 Weeks | 12.0 Weeks | 8.5 Weeks | 6.5 Weeks | 5.5 Weeks |
Tirzepatide Therapy (Brand & Compounded Options)
Description:
Tirzepatide is the active ingredient in diabetes and weight loss medications Mounjaro® and Zepbound®. In collaboration with a network of licensed medical providers, we offer comprehensive therapy plans that may include tirzepatide—either in its brand-name form or as a compounded alternative. This approach allows us to address your unique needs while ensuring you receive individualized care under professional medical supervision.
Key Features:
•Brand & Compounded Availability: Depending on prescription and insurance considerations, patients can access either brand-name tirzepatide (Mounjaro®, Zepbound®) or a compounded version prepared by a licensed pharmacy.
•Expert Medical Oversight: Our providers evaluate each patient’s metabolic profile and monitor ongoing progress, making treatment adjustments as needed for the best results.
•Patient-Centered Approach: Through personalized consultations, our team helps identify the option—brand-name or compounded—that best aligns with your health objectives and circumstances.
Important Information & Disclaimer:
•Compounded Medications: Compounded drug products are not approved or evaluated for safety, efficacy, or quality by the FDA. However, our partner pharmacies are licensed by the Board of Pharmacy and comply with FDA regulations under 503A and 503B.
•Brand Medications: Brand-name products (Mounjaro®, Zepbound®) have undergone FDA review; any questions about FDA approval should be discussed with your healthcare provider.
•Medical Supervision: Always consult a qualified healthcare professional regarding your personal health situation and the suitability of tirzepatide therapy for your needs.
•No Claims of Cure: This therapy is not intended to diagnose, treat, cure, or prevent any disease.
These statements have not been evaluated by the Food and Drug Administration. Please consult with your licensed medical provider for individualized medical advice.
If you’re ineligible to receive therapy or medications after consultation with Valhalla Vitality provider – you will be fully refunded!
Book a consultation to speak to a provider about treatment options
